Patrick John Finn - 22 Dec 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Commercial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for Patrick John Finn
Issuer symbol
TWST
Transactions as of
22 Dec 2021
Net transactions value
-$457,162
Form type
4
Filing time
27 Dec 2021, 15:35:14 UTC
Previous filing
23 Dec 2021
Next filing
29 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $52,867 +5,994 +16% $8.82 44,228 22 Dec 2021 Direct
transaction TWST Common Stock Sale $510,029 -5,994 -14% $85.09 38,234 22 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -5,994 -39% $0.000000 9,273 22 Dec 2021 Common Stock 5,994 $8.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 16, 2021.
F2 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.